301 related articles for article (PubMed ID: 18077358)
1. Modulation of human natural killer T cell ligands on TLR-mediated antigen-presenting cell activation.
Salio M; Speak AO; Shepherd D; Polzella P; Illarionov PA; Veerapen N; Besra GS; Platt FM; Cerundolo V
Proc Natl Acad Sci U S A; 2007 Dec; 104(51):20490-5. PubMed ID: 18077358
[TBL] [Abstract][Full Text] [Related]
2. Human invariant NKT cells display alloreactivity instructed by invariant TCR-CD1d interaction and killer Ig receptors.
Patterson S; Chaidos A; Neville DC; Poggi A; Butters TD; Roberts IA; Karadimitris A
J Immunol; 2008 Sep; 181(5):3268-76. PubMed ID: 18713998
[TBL] [Abstract][Full Text] [Related]
3. Cutting edge: nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cells.
Silk JD; Salio M; Reddy BG; Shepherd D; Gileadi U; Brown J; Masri SH; Polzella P; Ritter G; Besra GS; Jones EY; Schmidt RR; Cerundolo V
J Immunol; 2008 May; 180(10):6452-6. PubMed ID: 18453560
[TBL] [Abstract][Full Text] [Related]
4. Innate-like control of human iNKT cell autoreactivity via the hypervariable CDR3beta loop.
Matulis G; Sanderson JP; Lissin NM; Asparuhova MB; Bommineni GR; Schümperli D; Schmidt RR; Villiger PM; Jakobsen BK; Gadola SD
PLoS Biol; 2010 Jun; 8(6):e1000402. PubMed ID: 20585371
[TBL] [Abstract][Full Text] [Related]
5. Invariant NKT cells facilitate cytotoxic T-cell activation via direct recognition of CD1d on T cells.
Qin Y; Oh S; Lim S; Shin JH; Yoon MS; Park SH
Exp Mol Med; 2019 Oct; 51(10):1-9. PubMed ID: 31653827
[TBL] [Abstract][Full Text] [Related]
6. Characterization and functional analysis of mouse invariant natural T (iNKT) cells.
Bezbradica JS; Stanic AK; Joyce S
Curr Protoc Immunol; 2006 Jul; Chapter 14():14.13.1-14.13.27. PubMed ID: 18432968
[TBL] [Abstract][Full Text] [Related]
7. IFN-gamma-producing human invariant NKT cells promote tumor-associated antigen-specific cytotoxic T cell responses.
Moreno M; Molling JW; von Mensdorff-Pouilly S; Verheijen RH; Hooijberg E; Kramer D; Reurs AW; van den Eertwegh AJ; von Blomberg BM; Scheper RJ; Bontkes HJ
J Immunol; 2008 Aug; 181(4):2446-54. PubMed ID: 18684935
[TBL] [Abstract][Full Text] [Related]
8. A closer look at CD1d molecules: new horizons in studying NKT cells.
Stronge VS; Salio M; Jones EY; Cerundolo V
Trends Immunol; 2007 Oct; 28(10):455-62. PubMed ID: 17825624
[TBL] [Abstract][Full Text] [Related]
9. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
[TBL] [Abstract][Full Text] [Related]
10. Exploiting the role of endogenous lymphoid-resident dendritic cells in the priming of NKT cells and CD8+ T cells to dendritic cell-based vaccines.
Petersen TR; Sika-Paotonu D; Knight DA; Simkins HM; Hermans IF
PLoS One; 2011 Mar; 6(3):e17657. PubMed ID: 21483862
[TBL] [Abstract][Full Text] [Related]
11. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.
Hermans IF; Silk JD; Gileadi U; Salio M; Mathew B; Ritter G; Schmidt R; Harris AL; Old L; Cerundolo V
J Immunol; 2003 Nov; 171(10):5140-7. PubMed ID: 14607913
[TBL] [Abstract][Full Text] [Related]
12. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids.
Paget C; Mallevaey T; Speak AO; Torres D; Fontaine J; Sheehan KC; Capron M; Ryffel B; Faveeuw C; Leite de Moraes M; Platt F; Trottein F
Immunity; 2007 Oct; 27(4):597-609. PubMed ID: 17950005
[TBL] [Abstract][Full Text] [Related]
13. Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases.
Gadola SD; Silk JD; Jeans A; Illarionov PA; Salio M; Besra GS; Dwek R; Butters TD; Platt FM; Cerundolo V
J Exp Med; 2006 Oct; 203(10):2293-303. PubMed ID: 16982810
[TBL] [Abstract][Full Text] [Related]
14. Turned on by danger: activation of CD1d-restricted invariant natural killer T cells.
Lawson V
Immunology; 2012 Sep; 137(1):20-7. PubMed ID: 22734667
[TBL] [Abstract][Full Text] [Related]
15. The actin cytoskeleton modulates the activation of iNKT cells by segregating CD1d nanoclusters on antigen-presenting cells.
Torreno-Pina JA; Manzo C; Salio M; Aichinger MC; Oddone A; Lakadamyali M; Shepherd D; Besra GS; Cerundolo V; Garcia-Parajo MF
Proc Natl Acad Sci U S A; 2016 Feb; 113(6):E772-81. PubMed ID: 26798067
[TBL] [Abstract][Full Text] [Related]
16. Sterile activation of invariant natural killer T cells by ER-stressed antigen-presenting cells.
Bedard M; Shrestha D; Priestman DA; Wang Y; Schneider F; Matute JD; Iyer SS; Gileadi U; Prota G; Kandasamy M; Veerapen N; Besra G; Fritzsche M; Zeissig S; Shevchenko A; Christianson JC; Platt FM; Eggeling C; Blumberg RS; Salio M; Cerundolo V
Proc Natl Acad Sci U S A; 2019 Nov; 116(47):23671-23681. PubMed ID: 31690657
[TBL] [Abstract][Full Text] [Related]
17. Innate self recognition by an invariant, rearranged T-cell receptor and its immune consequences.
Stanic AK; Park JJ; Joyce S
Immunology; 2003 Jun; 109(2):171-84. PubMed ID: 12757612
[TBL] [Abstract][Full Text] [Related]
18. Activation of decidual invariant natural killer T cells promotes lipopolysaccharide-induced preterm birth.
Li L; Yang J; Jiang Y; Tu J; Schust DJ
Mol Hum Reprod; 2015 Apr; 21(4):369-81. PubMed ID: 25589517
[TBL] [Abstract][Full Text] [Related]
19. Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy.
Silk JD; Hermans IF; Gileadi U; Chong TW; Shepherd D; Salio M; Mathew B; Schmidt RR; Lunt SJ; Williams KJ; Stratford IJ; Harris AL; Cerundolo V
J Clin Invest; 2004 Dec; 114(12):1800-11. PubMed ID: 15599405
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of CD1d-restricted invariant natural killer T cell-based treatment for autoimmune diseases.
Miyake S; Yamamura T
Int Rev Immunol; 2007; 26(1-2):73-94. PubMed ID: 17454265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
